Evidence map›Paper›PMID 23036785›Full record

Trial reportDiabetes research and clinical practice2012

Impact of inpatient diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge.

Deborah J Wexler, Catherine C Beauharnais, Susan Regan, David M Nathan, Enrico Cagliero, Mary E Larkin

2 registry-linked trialsOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Diabetes research and clinical practice, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00869362 nacompletednot on this map

Effect of Inpatient Diabetes Management on Outpatient Glycemic Control

TypeinterventionalSponsorMassachusetts General HospitalRan2009 to 2011Enrolled31ConditionsDiabetes Mellitus, Type 2ArmsDiabetes management team
NCT03455985 naterminatednot on this mapstarted 2018, after this paper: background citation

Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin

TypeinterventionalSponsorOhio State UniversityRan2018 to 2020Enrolled158ConditionsDiabetes Mellitus, Type 2, Patient Discharge, Blood Glucose, Low, Blood Glucose, HighArmsDischarge Order Set (DOS), Enhanced Standard Care (ESC)
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Observational
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Deborah J WexlerMassachusetts General Hospital Diabetes Center, Boston, MA 02114, USA. dwexler@partners.org
Catherine C Beauharnais
Susan Regan
David M Nathan
Enrico Cagliero
Mary E Larkin
Massachusetts General Hospital · USHarvard University · USBoston University · US

Funding

Effective Inpatient Diabetes Management and the Transition to Outpatient CareK23DK080228 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI WEXLER, DEBORAH J · 2007 to 2011
$772k
NIDDK NIH HHS K23 DK 080 228NIDDK NIH HHS K23 DK080228
6 · The paper itself

Abstract

aimTo determine whether inpatient diabetes management and education with improved transition to outpatient care (IDMET) improves glycemic control after hospital discharge in patients with uncontrolled type 2 diabetes (T2DM).

methodsAdult inpatients with T2DM and HbA1c > 7.5% (58 mmol/mol) admitted for reasons other than diabetes to an academic medical center were randomly assigned to either IDMET or usual care (UC). Linear mixed models estimated treatment-dependent differences in the change in HbA1c (measured at 3, 6, and 12 months) from baseline to 1-year follow-up.

resultsThirty-one subjects had mean age 55 ± 12.6 years, with mean HbA1c of 9.7 ± 1.6% (82 ± 18 mmol/mol). Mean inpatient glucose was lower in the IDMET than in the UC group (176 ± 66 versus 195 ± 74 mg/dl [9.7 versus 10.8 mmol/l], P = 0.001). In the year after discharge, the average HbA1c reduction was greater in the IDMET group compared with the UC group by 0.6% (SE 0.5%, [7 (SE 5)mmol/mol], P = 0.3). Among patients newly discharged on insulin, the average HbA1c reduction was greater in the in the IDMET group than in the UC group by 2.4% (SE 1.0%, [25 (SE 11)mmol/mol], P = 0.04).

conclusionsInpatient diabetes management (IDMET) substantially improved glycemic control 1 year after discharge in patients newly discharged on insulin; patients previously treated with insulin did not benefit.

Indexed as

AdultAgedBlood GlucoseDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansHypoglycemic AgentsInpatientsInsulinMaleMiddle AgedPatient DischargeBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulin

Identifiers

PMID23036785
PMCPMC3514591
OpenAlexW1970952605

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.